Biogen-Eisai’s Alzheimer’s drug gets 4-weekly dosing nod in US
Biogen Inc. and its Japanese partner, Eisai Co. Ltd., announced that the US regulator had approved four-weekly maintenance dosing for its Alzheimer's drug.
HQ Team January 27, 2025: Researchers at the Hubrecht Institute have discovered that a protein can restore a damaged heart by activating dormant
HQ Team January 26, 2025: Pharmaceutical giant AstraZeneca has announced plans to invest US$570 million in Canada over the next decade, positioning the
HQ Team January 26, 2025: Scientists from Delft University of Technology, Vienna Biocenter, and Lausanne have discovered that Structural Maintenance of Chromosomes (SMC)
HQ Team January 24, 2025: A recent study led by Empa researchers has developed a new mathematical model that improves predictions of how
HQ Team January 24, 2025: A comprehensive genome-wide association study (GWAS) has found 298 regions containing DNA variations for increased risk of bipolar
Hyundai ADM Bio, a subsidiary of South Korea’s Hyundai Bioscience, unveiled an oral cancer drug that allows patients to make a shift from intravenous
HQ Team January 22, 2025: The Panna Tiger Reserve in Central India has revived its tiger population from the brink of extinction to